(784) - Low Level Donor Specific Antibodies at Transplant Does Not Appear to Be Associated With the development of Cardiac Allograft Vasculopathy After Heart Transplantation

M Kittleson,J Patel,F Liou,S Siddiqui,J Yabuno,D.H Chang,D Ramzy,L Czer,F Esmailian,N Reinsmoen,J.A Kobashigawa

doi:10.1016/j.healun.2015.01.802

(784) - Low Level Donor Specific Antibodies at Transplant Does Not Appear to Be Associated With the development of Cardiac Allograft Vasculopathy After Heart Transplantation

M Kittleson, J Patel + Show 9 more

https://doi.org/10.1016/j.healun.2015.01.802

Copy DOI

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation	Publication Date: Apr 1, 2015
Citations: 1

#Development Of Cardiac Allograft Vasculopathy #Low Level Donor Specific Antibodies + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Donor specific antibodies (DSA) following heart transplant has been reported to be associated with increased development of cardiac allograft vasculopathy (CAV) and risk of mortality following transplantation. In the era of virtual crossmatch, we may now elect to place donor hearts in patients with low level DSAs that are not placed as avoids. The effect of these low level DSAs on the development of CAV has not yet been established.

Full Text